← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2006Last known activity
Jun 1, 2024
Timeline
1620s
- Jan 1, 1623
Pontificia Universidad Javeriana— Founded
Drugs by trial phase (18 distinct, 14 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (25)
- NCT06857110CollaboratorN/AJun 1, 2024
- NCT05587088CollaboratorPhase 1/Phase 2Dec 15, 2022
- NCT05007444CollaboratorPhase 2Oct 1, 2021
- NCT04684550Overall official - principal investigatorPhase 2/Phase 3Feb 15, 2021
- NCT04684550CollaboratorPhase 2/Phase 3Feb 15, 2021
- NCT04527211Reponsible party - principal investigatorPhase 3Sep 7, 2020
- NCT04527211Lead sponsorPhase 3Sep 7, 2020
- NCT04527211Overall official - principal investigatorPhase 3Sep 7, 2020
- NCT04519125CollaboratorPhase 2/Phase 3Aug 30, 2020
- NCT04410510CollaboratorPhase 2/Phase 3Jun 30, 2020
- NCT04359095CollaboratorPhase 2/Phase 3May 11, 2020
- NCT03663881CollaboratorPhase 1Oct 31, 2018
- NCT05346978Sponsor investigatorN/AJun 1, 2018
- NCT05346978Overall official - principal investigatorN/AJun 1, 2018
- NCT05346978Reponsible party - principal investigatorN/AJun 1, 2018
Details
- Founded
- Bogota, CO Jan 1, 1623
- Last known activity
- Jun 1, 2024